CORPORATE TRAVEL MANAGEMENT LIMITED (CTD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CTD

CTD - CORPORATE TRAVEL MANAGEMENT LIMITED

FNArena Sector : Travel, Leisure & Tourism
Year End: June
GICS Industry Group : Consumer Services
Debt/EBITDA: 0.2
Index: ASX200 | ASX300 | ALL-ORDS

Corporate Travel is an Australian provider of travel solutions to the corporate market. Founded in 1994, the company listed on the ASX in 2010.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$16.07

26 Aug
2025

0.000

OPEN

$16.07

0.000

HIGH

$16.07

0

LOW

$16.07

TARGET
$14.933 -7.1% downside
OTHER COMPANIES IN THE SAME SECTOR
AIA . AIZ . CEH . CHL . EVT . EXP . FLT . HLO . KLS . QAN . SDR . SKO . SST . THL . VGL . VRL . VVA . WEB . WJL .
FNARENA'S MARKET CONSENSUS FORECASTS
CTD: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 57.9 58.6 xxx
DPS (cps) xxx 29.0 25.3 xxx
EPS Growth xxx 9.0% 1.2% xxx
DPS Growth xxx 3.6% - 12.9% xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A N/A xxx
Div Pay Ratio(%) xxx 50.1% 43.1% xxx

Dividend yield today if purchased 3 years ago: 1.70%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.80

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx57.9
DPS All xxxxxxxxxxxxxxx29.0
Sales/Revenue xxxxxxxxxxxxxxx707.7 M
Book Value Per Share xxxxxxxxxxxxxxx812.2
Net Operating Cash Flow xxxxxxxxxxxxxxx126.8 M
Net Profit Margin xxxxxxxxxxxxxxx11.93 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx7.19 %
Return on Invested Capital xxxxxxxxxxxxxxx7.02 %
Return on Assets xxxxxxxxxxxxxxx4.91 %
Return on Equity xxxxxxxxxxxxxxx7.19 %
Return on Total Capital xxxxxxxxxxxxxxx11.00 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx64.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx10 M
Long Term Debt xxxxxxxxxxxxxxx29 M
Total Debt xxxxxxxxxxxxxxx39 M
Goodwill - Gross xxxxxxxxxxxxxxx923 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx135 M
Price To Book Value xxxxxxxxxxxxxxx1.63

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx47.6 M
Capex % of Sales xxxxxxxxxxxxxxx6.72 %
Cost of Goods Sold xxxxxxxxxxxxxxx552 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx21 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx7 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

05/05/2025

1

Add

$16.05

-0.12%

Morgans maintains an Add rating on Corporate Travel Management and cuts its target price to $16.05 from $18.72 following a weaker-than-expected trading update driven by tariffs and macroeconomic uncertainty.

FY25 EBITDA guidance has been reduced by -$30m (-15.3%) to $167m, reflecting softer US and Asian trading, and the impact of delayed client activity, explain the analysts.

Despite this, management reported record new client wins of over $1.6bn, well above its $1bn target, which are expected to support FY26 earnings growth.

While Europe remains resilient, the broker notes North America and A&NZ are expected to post second-half earnings (EBITDA) declines of -12.5% and -8.3% respectively.

Management now targets FY26 EBITDA of $205m, below the original $239m guidance, but Morgans expects this to be achieved by FY27.

Despite near-term headwinds, management is confident in long-term growth, aiming to double statutory EPS by FY29 through client acquisition, margin improvement, and automation, observes the broker.

FORECAST
Morgans forecasts a full year FY25 dividend of 25.00 cents and EPS of 60.80 cents.
Morgans forecasts a full year FY26 dividend of 32.50 cents and EPS of 78.60 cents.

Shaw and Partners

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxxxxxx xx xxxxx-xxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

08/05/2025

2

Overweight

$16.00

-0.44%

Jarden lowers its FY25 EBITDA forecast for Corporate Travel Management by around -15% due to softer-than-expected trading conditions, particularly in A&NZ, Asia, and the US.

FY25 revenue is now projected to be around -4% below previous guidance, while the FY26 revenue growth estimate is cut to 5.4% from 10%, and the earnings margin reduced to 28% from 30%. 

Despite these downgrades, Jarden highlights a solid operational performance with $1.6bn in new client wins versus a $1bn target, 97% client retention, and 80-90% cash conversion.

The broker considers the long-term outlook is intact, with the company continuing to take market share and retains an Overweight rating. The target price is lowered to $16.00 from $17.00.

FORECAST
Jarden forecasts a full year FY25 EPS of 60.30 cents.
Jarden forecasts a full year FY26 EPS of 83.80 cents.

CTD STOCK CHART